Cytoplasmic retention renders this RAD52 variant nonfunctional leading apparently to attrition of BRCA2-deficient breast cancer cells (Adamson et al., 2020; Biswas and Sharan 2020). The gene discussed is RAD52; the disease is breast cancer.